ArticleJournal of hepatology2026

Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma.

Tim Meyer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.